Chicago-based Stella, which specializes in comprehensive treatment for post traumatic stress, anxiety, stress, depression, traumatic brain injury, and Long COVID, raised $7M in funding.
The capital raise will be used to advance Stella’s industry leading mental health research and open locations across the US and abroad.
Stella, a Sterling Partners company, also unveiled its new flagship facility in Chicago, which will serve as a hub for treatments, research, and medical training – including hosting clinical trials and uncovering effective, science-backed treatment protocols and methodologies.
Founded in 2020, Stella has treated over 6,000 patients to date. Stella targets the physical injury caused by mental trauma with biological interventions. Read more.
